The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Chitosan and chitosan coating nanoparticles for the treatment of brain disease
Abstract
&NA; Since the application of chitosan magnetic cationic microspheres in brain drug delivery by Gallo in 1993, chitosan has been extensively studied in brain drug delivery. As the only natural alkaline polysaccharide with good biocompatibility and biodegradability, chitosan prepared nanoparticles which use chitosan as carrier material to encapsulate drug have been proved with advantages of protecting from enzyme degradation, control release and improved bioavailability. Besides, chitosan can enhance drug permeability across the blood‐brain barrier by affecting the tight junction. And with positive charge on the surface, chitosan nanoparticles can absorb on the negatively charged cell membrane, thus increase its residence time on the nasal mucosa and benefit of the delivery of drugs from the nasal cavity to the brain. All these properties made chitosan nanoparticles especially suitable for brain delivery. What's more, the free amino groups on the surface of chitosan nanoparticles allow specific chemical modification to form a wide range of chitosan derivatives. Surface modification of the nanoparticles with tumor targeting peptides like chlorotoxin and transferrin, can further improve the targeting property to brain tumor. This article gives a comprehensive review on the advantages and recent progresses in the treatment of brain disease by chitosan nanoparticles. Graphical abstract Figure. No caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
Biodegradation, biodistribution and toxicity of chitosan
Kean, T., & Thanou, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.004 · Cited by 1,837
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Antimicrobial Chitosan and Chitosan Derivatives: A Review of the Structure–Activity Relationship
Sahariah, P., & Másson, M. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01058 · Cited by 994
Extraction, chemical modification and characterization of chitin and chitosan
El Knidri, H., Belaabed, R., Addaou, A., Laajeb, A., & Lahsini, A. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.08.139 · Cited by 805
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Delivery of peptides and proteins through the blood–brain barrier
Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 481
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Cited by
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
Xiong, B., Wang, Y., Chen, Y., Xing, S., Liao, Q., Chen, Y., Li, Q., Li, W., & Sun, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00910 · Cited by 232
Dendrimer-Based Drug Delivery Systems for Brain Targeting
Zhu, Y., Liu, C., & Pang, Z. (2019) · Biomolecules · doi:10.3390/biom9120790 · Cited by 220
Seyam, S., Nordin, N. A., & Alfatama, M. (2020) · Pharmaceuticals · doi:10.3390/ph13100307 · Cited by 85
Jiao, Y., Yang, L., Wang, R., Song, G., Fu, J., Wang, J., Gao, N., & Wang, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121611 · Cited by 63
Metadata
- Authors
- Yu, S., Xu, X., Feng, J., Liu, M., & Hu, K.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 560
- Pages
- 282-293
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2911297145
- Cited by
- 340
- References
- 77
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chitosan and chitosan coating nanoparticles for the treatment of brain disease. https://app.cochat.ai/papers/10.1016/j.ijpharm.2019.02.012
- The paper
- Yu, S., Xu, X., Feng, J., Liu, M., & Hu, K. (2019). Chitosan and chitosan coating nanoparticles for the treatment of brain disease. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2019.02.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.